Skip to main content
SpringerLink
Log in

miR-141 as potential suppressor of β-catenin in breast cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Triple negative breast cancer (TNBC) is well known for its heterogeneous features and lack of targeted therapy. A variety of cell signaling pathways have been linked to the initiation and progression of these tumors where canonical Wnt signaling is one of the main candidate pathways. Considering past literatures on this matter and negative reports regarding mutations in β-catenin gene (CTNNB1), we focus our attention to another level of gene expression control level, microRNAs (miRNAs). For proper miRNA target detection, we utilized bioinformatics as a relatively new and reliable tool for miRNA: mRNA prediction. MDA-MB-231 (invasive breast cancer) and MCF-10A (normal breast) cell lines were chosen as models. We used different bioinformatic tools such as TargetScan, miRanda, etc. For miRNA targeting CTNNB1-3´UTR confirmation, luciferase assay was carried out. miRNA expression was induced in cell lines through viral constructs expressing desired miRNA. Quantitative real-time PCR was performed for the measurement of expression levels of selected miRNA and target gene. miR-141 was selected via expanded search among various bioinformatic tools. miR-141 expression level was downregulated in MDA-MB-231 cell line, and CTNNB1 gene expression was upregulated. After transduction with viral construct, miR-141 expression was elevated in both cell lines, and gene expression was notably decreased. β-Catenin can be considered as one of the main players in these tumors’ pathogenesis. Also, it is the potential target of miR-141, in which its downregulation was detected in cell lines, and can be considered as a promising new targeted approach toward TNBC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Singh R, Mo Y-Y. Role of microRNAs in breast cancer. Cancer Biol Ther. 2013;14(3):201–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer: implications in diagnosis and treatment. World J Clin Oncol. 2014;5(2):48.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Avery-Kiejda KA et al. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer. BMC Cancer. 2014;14(1):51.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gasparini P et al. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget. 2014;5(5):1174.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Schneider BP et al. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008;14(24):8010–8.

    Article  CAS  PubMed  Google Scholar 

  6. Kamdje AHN et al. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. Cell Signal. 2014;26(12):2843–56.

    Article  Google Scholar 

  7. Howe LR, Brown AM. Wnt signaling and breast cancer. Cancer Biol Ther. 2004;3(1):36–41.

    Article  CAS  PubMed  Google Scholar 

  8. Chu EY et al. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development. 2004;131(19):4819–29.

    Article  CAS  PubMed  Google Scholar 

  9. Khramtsov AI et al. Wnt/β-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol. 2010;176(6):2911–20.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hatsell S et al. β-Catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia. 2003;8(2):145–58.

    Article  PubMed  Google Scholar 

  11. Cai J et al. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. J Clin Invest. 2013;123(2):566.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10(2):126–39.

    Article  CAS  PubMed  Google Scholar 

  13. Cai Y et al. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 2009;7(4):147–54.

    Article  CAS  PubMed  Google Scholar 

  14. Winter J et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228–34.

    Article  CAS  PubMed  Google Scholar 

  15. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006;66(15):7390–4.

    Article  CAS  PubMed  Google Scholar 

  16. Nana-Sinkam SP, Fabbri M, Croce CM. MicroRNAs in cancer: personalizing diagnosis and therapy. Ann N Y Acad Sci. 2010;1210(1):25–33.

    Article  CAS  PubMed  Google Scholar 

  17. Faryal R. Role of miRNAs in breast cancer. Asian Pac J Cancer Prev. 2011;12:3175–80.

    PubMed  Google Scholar 

  18. Mendes N, Freitas AT, Sagot M-F. Current tools for the identification of miRNA genes and their targets. Nucleic Acids Res. 2009;37(8):2419–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Al-Rajab M. and J. Lu, Bioinformatics: an overview for cancer research. 2012.

  20. Mount, D.W., Sequence and genome analysis. Bioinformatics: Cold Spring Harbour Laboratory Press: Cold Spring Harbour. 2004; 2.

  21. Dull T et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72(11):8463–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Huang K et al. MicroRNA roles in beta-catenin pathway. Mol Cancer. 2010;9(1):252.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Zhao H et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010;5(10), e13735.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Xin F et al. Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics. 2009;25(4):430–4.

    Article  CAS  PubMed  Google Scholar 

  25. Wang C et al. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J Exp Clin Cancer Res. 2012;31(1):58.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mohammadi-Yeganeh S et al. Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis. Mol Biol Rep. 2013;40(5):3665–74.

    Article  CAS  PubMed  Google Scholar 

  27. Bilir B, Kucuk O, Moreno CS. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med. 2013;11(1):280.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Esau C et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem. 2004;279(50):52361–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was funded by Pasteur Institute of Iran, Tehran. The authors appreciate Stem Cell Technology Research Center, Tehran, Iran, and also Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences,Tehran, Iran for providing technical support. The authors would like to thank Mr. Vahid Kia for final proofreading of the manuscript.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of New Sciences, Tehran Medical Branch, Islamic Azad University, Tehran, Iran

    Nairi Abedi & Fariba Karami

  2. Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Samira Mohammadi-Yeganeh & Ameneh Koochaki

  3. Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Samira Mohammadi-Yeganeh & Ameneh Koochaki

  4. Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran

    Mahdi Paryan

Authors
  1. Nairi Abedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samira Mohammadi-Yeganeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ameneh Koochaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fariba Karami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mahdi Paryan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Samira Mohammadi-Yeganeh or Mahdi Paryan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abedi, N., Mohammadi-Yeganeh, S., Koochaki, A. et al. miR-141 as potential suppressor of β-catenin in breast cancer. Tumor Biol. 36, 9895–9901 (2015). https://doi.org/10.1007/s13277-015-3738-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3738-y

Keywords

Search

Navigation